Simon J Clark

Title: Simon J Clark: Innovator in Age-Related Macular Degeneration Research

Introduction

Simon J Clark is a notable inventor based in Oxford, GB. He has made significant contributions to the field of medical research, particularly in the area of age-related macular degeneration (AMD). His work focuses on identifying agents that can inhibit specific biological interactions, which may lead to advancements in treatment options for this condition.

Latest Patents

Simon J Clark holds a patent titled "Screening assays for binding antagonists of the AMD-associated variant of factor H (H384)." This invention relates to the identification of agents that preferentially inhibit binding to targets such as heparin of the H384 allotypic variant of human complement Factor H. This variant is associated with AMD, and the invention aims to differentiate its binding properties from the non-disease associated form (Y384). The ability to identify antagonists that target these specific interactions is crucial for developing effective treatments for AMD.

Career Highlights

Simon J Clark is affiliated with the University of Manchester, where he conducts his research. His work has garnered attention for its potential impact on understanding and treating AMD. With a focus on innovative solutions, he continues to contribute to the scientific community through his research and patent activities.

Collaborations

Simon collaborates with esteemed colleagues, including Anthony Day and Paul Bishop. Their combined expertise enhances the research efforts aimed at addressing the challenges posed by age-related macular degeneration.

Conclusion

In summary, Simon J Clark is a dedicated inventor whose work in the field of age-related macular degeneration holds promise for future treatments. His innovative approach and collaboration with other experts underscore the importance of research in advancing medical science.